Chronic Antibody-Mediated Rejection: B-Cell Dependent Alloreactive IFNγ-Producing CD4+ T Cells Could Be Used as a Biomarker To Determine Responsiveness to Therapy

    Research output: Chapter in Book/Report/Conference proceedingPoster abstract

    Abstract


    Original languageEnglish
    Title of host publication2012 AMERICAN TRANSPLANT CONGRESS
    Publication statusPublished - May 2012

    Cite this